Jun Wang

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Wen‐Zhao Zhong, Qun Wang, Weimin Mao et al. · The Lancet Oncology · 2017 · 520 citations

Medicine, Pathology, Gefitinib Versus Vinorelbine +8

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week

Yawei Hu, Xizhao Sui, Fan Song et al. · Nature Communications · 2021 · 247 citations · Full text

Engineering, Organ-on-a-chip, Biomedical Engineering +20

Perioperative Dynamic Changes in Circulating Tumor DNA in Patients with Lung Cancer (DYNAMIC)

Kezhong Chen, Heng Zhao, Yanbin Shi et al. · Clinical Cancer Research · 2019 · 230 citations

Tumor Tissue-Derived Formaldehyde and Acidic Microenvironment Synergistically Induce Bone Cancer Pain

Zhiqian Tong, Wenhong Luo, Yan-Qing Wang et al. · PLoS ONE · 2010 · 123 citations · Full text

Pilomatrixoma: Clinicopathologic study of 51 cases with emphasis on cytologic features

Jun Wang, Camilla J. Cobb, Sue Martin et al. · Diagnostic Cytopathology · 2002 · 100 citations

Cytologic Features, Urology, Medicine +10